PODD

Insulet's stock price has experienced significant volatility and a notable decline over the past six months, falling 58.04% from $335.12 to $140.60. Key events include two voluntary Medical Device Corrections for Omnipod Pods in March and May 2026 due to manufacturing issues that could lead to insulin under-delivery, which caused stock drops of 6.88% and 5.07% respectively, and resulted in securities class action lawsuits. Earnings reports for Q4 2025 (February 18, 2026), Q1 2026 (May 6, 2026, with 33.9% revenue increase), and Q2 2026 (August 5, 2026, with 23.5% revenue growth but a ~20% stock drop due to lowered FY2026 guidance) also impacted the stock. Additionally, Timothy J. Scannell resigned from the Board on September 3, 2026, for health reasons, and Michael R. Minogue stepped down on September 8, 2026, to pursue political candidacy.